Collegium Pharm

COLL NASDAQ
12.62
+0.23
+1.86%
盘后: 12.62 0 0.00% 18:07 06/25 EDT
开盘
12.53
昨收
12.39
最高
12.83
最低
12.48
成交量
25.62万
成交均量(3M)
34.70万
52周最高
26.43
52周最低
10.55
换手率
0.77%
市值
4.21亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Collegium Pharm COLL股票价格,Collegium Pharm股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. Xtampza ER is designed to provide adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. ONSOLIS is a Transmucosal Immediate-Release Fentanyl (TIRF) film indicated for the management of breakthrough pain in cancer patients (BTPc), 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
展开 >

最近浏览

名称
价格
涨跌幅